Key facts
- Notable investors include Hiway Capital, Huaou Equity Investment, Jiuding Group, Kunwu Jiuding Investment Holding.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Qili Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Qili Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qili Pharmaceutical
Manufacturer of pharmaceutical products intended for hospitals, pharmacies, and healthcare providers seeking reliable drug formulations for patient care. The company is engaged in the production of prescription drugs, over-the-counter medicines, and therapeutic formulations, thereby enabling medical institutions to gain access to consistent quality and therapeutic reliability.
- Sector
- Healthcare
- HQ
- Haikou, China
- Founded
- 1997
- Employees
- 563
- Website
- hkqili.com/
- Ownership
- Privately Held (backing)
Qili Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qili Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qili Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.